UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NCLH icon
551
PUT
Norwegian Cruise Line
NCLH
$6.84B
$839K 0.02%
69,200
– –
2021 Q2
6 quarters
SCYX icon
552
SCYNEXIS
SCYX
$39.1M
$836K 0.02%
66,959
– –
2022 Q2
2 quarters
CSII
553
DELISTED
Cardiovascular Systems, Inc.
CSII
$831K 0.02%
61,040
+15,637
+34% +$218K
2022 Q1
3 quarters
WEN icon
554
Wendy's
WEN
$1.21B
$830K 0.02%
36,671
-392,329
-91% -$8.38M
2022 Q3
1 quarter
ANNX icon
555
Annexon
ANNX
$717M
$822K 0.02%
158,959
+37,202
+31% +$204K
2022 Q1
3 quarters
BHAC icon
556
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$818K 0.02%
81,132
-157,491
-66% -$1.58M
2021 Q4
4 quarters
AXSM icon
557
Axsome Therapeutics
AXSM
$8.52B
$809K 0.01%
10,491
+5,491
+110% +$328K
2022 Q1
3 quarters
QURE icon
558
uniQure
QURE
$1.43B
$793K 0.01%
+35,000
New +$755K
2022 Q4
0 quarters
PHM icon
559
Pultegroup
PHM
$20.6B
$783K 0.01%
+17,194
New +$724K
2022 Q4
0 quarters
DCPH icon
560
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$779K 0.01%
47,500
+37,500
+375% +$610K
2022 Q3
1 quarter
CRC icon
561
California Resources
CRC
$4.79B
$772K 0.01%
17,736
-290
-2% -$12.7K
2020 Q4
8 quarters
IMUX icon
562
Immunic
IMUX
$88.1M
$770K 0.01%
54,989
+35,190
+178% +$960K
2022 Q1
3 quarters
NNN icon
563
NNN REIT
NNN
$7.87B
$762K 0.01%
16,643
+4,443
+36% +$193K
2021 Q4
4 quarters
ZTO icon
564
ZTO Express
ZTO
$15.2B
$760K 0.01%
28,283
-123,957
-81% -$2.85M
2021 Q2
6 quarters
DHI icon
565
D.R. Horton
DHI
$37B
$739K 0.01%
8,295
-57,239
-87% -$4.59M
2022 Q2
2 quarters
EXPE icon
566
PUT
Expedia Group
EXPE
$32.5B
$711K 0.01%
13,500
– –
2022 Q2
2 quarters
NBIX icon
567
Neurocrine Biosciences
NBIX
$13.8B
$709K 0.01%
5,940
-11,063
-65% -$1.3M
2022 Q1
3 quarters
SVRA icon
568
Savara
SVRA
$970M
$700K 0.01%
451,441
+70,611
+19% +$96.8K
2022 Q2
2 quarters
GLUE icon
569
Monte Rosa Therapeutics
GLUE
$849M
$692K 0.01%
90,979
-636
-0.7% -$5.3K
2022 Q1
3 quarters
APTV icon
570
Aptiv
APTV
$9.03B
$667K 0.01%
7,163
-72,115
-91% -$6.85M
2022 Q3
1 quarter
LRMR icon
571
Larimar Therapeutics
LRMR
$223M
$658K 0.01%
+159,412
New +$544K
2022 Q4
0 quarters
IQV icon
572
IQVIA
IQV
$43.2B
$653K 0.01%
3,185
-15,319
-83% -$3.11M
2022 Q2
2 quarters
EQT icon
573
EQT Corp
EQT
$33.1B
$624K 0.01%
18,439
-24,742
-57% -$993K
2021 Q3
5 quarters
MHO icon
574
M/I Homes
MHO
$3.1B
$613K 0.01%
13,283
-3,950
-23% -$170K
2022 Q2
2 quarters
FUSN icon
575
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$600K 0.01%
190,501
+173,215
+1,002% +$431K
2022 Q3
1 quarter
21 22
23
24 25

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.